SEC Company Response from VERTEX PHARMACEUTICALS (VRTX) — Feb 14, 2005
VERTEX PHARMACEUTICALS INC / MA (VRTX) (CIK 0000875320)
Date: Feb. 14, 2005 · CIK: 0000875320 · Accession: 0001047469-05-003718
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-120055
Letter
'
VERTEX PHARMACEUTICALS INCORPORATED
130 WAVERLY STREET • CAMBRIDGE, MA 02139-4242
TEL. 617.444.6100 • FAX 617.444-6483
http://www.vrtx.com
February 14,
Filed by EDGAR
Securities and Exchange Commission
450 Fifth Street, N.W.
Washington, D.C. 20549
Attn: Sonia Barros, Esq.
Re:Vertex Pharmaceuticals Registration Statement on Form S-3/A
SEC File No. 333-120055
Ladies and Gentlemen:
Reference is hereby made to a certain pre-effective Amendment No. 2 to the Registration Statement on Form S-3/A of Vertex Pharmaceuticals Incorporated (the "Registrant"), registration number 333-120055 (the "Amended Registration Statement") filed earlier today.
In connection with the Registrant's request for effectiveness of the Amended Registration Statement, the Registrant confirms that:
•should the Commission or the Staff, acting pursuant to delegated authority, declare the Amended Registration Statement effective, it does not foreclose the Commission or the Staff from taking any action with respect to the Amended Registration Statement;
•the action of the Commission or the Staff, acting pursuant to delegated authority, in declaring the filing effective does not relieve the Registrant from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and
•the Registrant may not assert any such action as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
The Registrant hereby requests that the Commission take appropriate action to cause the above-referenced Registration Statement on Form S-3/A to become effective at 4:45 p.m., Eastern Time, on February 14, 2005.
Very truly yours,
/s/ JEFFREY P. DONOHUE Jeffrey P. Donohue
Show Raw Text
CORRESP
1
filename1.htm
'
VERTEX PHARMACEUTICALS INCORPORATED
130 WAVERLY STREET • CAMBRIDGE, MA 02139-4242
TEL. 617.444.6100 • FAX 617.444-6483
http://www.vrtx.com
February 14,
2005
Filed by EDGAR
Securities
and Exchange Commission
450 Fifth Street, N.W.
Washington, D.C. 20549
Attn: Sonia Barros, Esq.
Re:Vertex Pharmaceuticals Registration Statement on Form S-3/A
SEC File No. 333-120055
Ladies
and Gentlemen:
Reference
is hereby made to a certain pre-effective Amendment No. 2 to the Registration Statement on Form S-3/A of Vertex Pharmaceuticals
Incorporated (the "Registrant"), registration number 333-120055 (the "Amended Registration
Statement") filed earlier today.
In
connection with the Registrant's request for effectiveness of the Amended Registration Statement, the Registrant confirms that:
•should
the Commission or the Staff, acting pursuant to delegated authority, declare the Amended Registration Statement effective, it does not foreclose the Commission or the
Staff from taking any action with respect to the Amended Registration Statement;
•the
action of the Commission or the Staff, acting pursuant to delegated authority, in declaring the filing effective does not relieve the Registrant from its full
responsibility for the adequacy and accuracy of the disclosure in the filing; and
•the
Registrant may not assert any such action as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United
States.
The
Registrant hereby requests that the Commission take appropriate action to cause the above-referenced Registration Statement on Form S-3/A to become effective at
4:45 p.m., Eastern Time, on February 14, 2005.
Very truly yours,
/s/ JEFFREY P. DONOHUE Jeffrey P. Donohue
Corporate Counsel
Vertex Pharmaceuticals Incorporated